Davis Polk – Silver Spring Networks Initial Public Offering

Davis Polk advised Goldman, Sachs & Co. and Credit Suisse Securities (USA) LLC as representatives of the several underwriters on the $92.86 million initial public offering of 5,462,500 shares of common stock of Silver Spring Networks, Inc., including 712,500 shares from the full exercise of the underwriters’ option to purchase additional shares. Silver Spring Networks’s common stock is traded on the New York Stock Exchange under the symbol “SSNI.”

More >>

Tags:  Davis Polk & Wardwell LLP | Silicon Valley

Simpson Thacher Represents CBRE in $800 Million Senior Notes Offering

Simpson Thacher recently represented CBRE Group, Inc. in connection with the offering of $800 million aggregate principal amount of 5.00% Senior Notes due 2023 (the “Notes”). The Notes were issued by CBRE Services, Inc., a wholly-owned subsidiary of CBRE Group, Inc., and are guaranteed by CBRE Group, Inc. and the subsidiaries that guarantee its senior secured credit facility. The Notes are being offered pursuant to an effective shelf registration statement that CBRE Group, Inc. previously filed with the Securities and Exchange Commission.

More >>

Tags:  Simpson Thacher & Bartlett LLP | Silicon Valley

O’Melveny Represents Synacor in Formation of Joint Venture with Maxit Technology

O’Melveny & Myers LLP represented Synacor, the leading provider of next-gen startpages, TV Everywhere solutions, and cloud-based Identity Management services across multiple devices for cable, satellite, telecom, and consumer electronics companies, in its formation of a joint venture with Beijing-based Maxit Technology Inc., a leading intelligent Internet platform company.

More >>

Tags:  O'Melveny & Myers, LLP | Silicon Valley

Cooley Advises Jazz Pharmaceuticals in $314.4 Million Offering

Cooley LLP announced today that it advised Jazz Pharmaceuticals plc (NASDAQ: JAZZ) in a recent $314.4 million public offering of its ordinary shares by certain of Jazz Pharmaceutical’s existing shareholders, including entities affiliated with Kohlberg Kravis Roberts, Longitude Capital Partners and Beecken Petty O’Keefe & Company.  Jazz Pharmaceuticals, a long-time Cooley client, is a specialty biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing innovative products that address unmet medical needs. The company, which is headquartered in Dublin, Ireland with multiple offices in the United States, the United Kingdom and other countries in Europe, has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.

More >>

Tags:  Cooley LLP | Silicon Valley

Davis Polk Advises Equinix, Inc. on Its $1.5 Billion High-Yield Notes Offering

Davis Polk advised Equinix, Inc. on its SEC-registered offering of $500 million aggregate principal amount of its 4.875% senior notes due 2020 and $1 billion aggregate principal amount of its 5.375% senior notes due 2023. J.P. Morgan Securities LLC, Barclays Capital Inc., Citigroup Global Markets Inc., Merrill Lynch, Pierce, Fenner & Smith Incorporated and Deutsche Bank Securities Inc. acted as joint book-running managers for the offering.

More >>

Tags:  Davis Polk & Wardwell LLP | Silicon Valley